Diseases & Conditions >
This topic is from 5-Minute Urology Consult
Dr. Gomella's off-label usage statement   About our sources

Myelodysplasia, Urologic Considerations Updated 12/2009

Clifford Georges, MD, Mark Horowitz, MD, Rosalia Misseri, MD
Feedback Form
Email       Print Section  |  Print Topic       Add to My Favorites

BASICS

  • Description
  • Epidemiology
  • Risk Factors
  • General Prevention
  • Pathophysiology
  • Associated Conditions

DIAGNOSIS

  • Signs and Symptoms
  • Tests
  • Differential Diagnosis

TREATMENT

  • Medication (Drugs)
  • Surgery
  • Complementary and Alternative Medicine

Ongoing Care

  • Prognosis
  • Complications
  • Follow-Up Recommendations
The following is an excerpt....
BASICS
Description
  • Myelodysplasia (spinal dysraphism, neural tube defect) is a very broad term encompassing a large heterogeneous group of congenital vertebral column defects that result from defects that occur during neural tube closure.
  • This includes a group of developmental abnormalities that can be open (meningocele, myelomeningocele, lipomyelomeningocele) or closed (spina bifida occulta, posterior meningoceles, lipomyelomeningocele, and myelocystocele).
  • Primary functional deficits can be lower limb paralysis and sensory loss, bladder and bowel dysfunction, and cognitive dysfunction.
  • Affected children often have varying degrees of neurogenic bladder dysfunction.
ALERT:
Patients with myelodysplasia have a high incidence of latex allergy.
Epidemiology
  • Open spinal dysraphism:
    • 1 in every 1,000 births in US
    • 2.5 times more common in whites than blacks
    • Incidence decreasing over ...

You must be logged in to fully access this content.

Sign In
Sign up for a 30-Day Free Trial

Sign up for a 30-Day FREE Trial now and receive access to all content.

Start free trial!

Have a book code?

Submit your book code to create your account.
See Also
Images >
1
Auer rods CELL TYPE: Myeloblasts and monoblasts (rare) DESCRIPTION: Reddish-purple rod-shaped cytoplasmic inclusions Alignment of primary granules CLINICAL CONDITIONS: M 1 , M 2 , M 3 , M 4 , M 6 CML in blastic transformation Myelodysplastic syndrome--RAEB-IT Credit: From Anderson's Atlas of Hematology; Anderson, Shauna C., PhD. Copyright 2003, Wolters Kluwer Health/Lippincott Williams & Wilkins.